
Lasa Supergenerics Ltd is Rated Strong Sell
2026-08-20 10:10:22Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 20 August 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news articleAre Lasa Supergenerics Ltd latest results good or bad?
2026-08-14 19:53:31Lasa Supergenerics Ltd's latest financial results for the fourth quarter of FY26 reveal a significant operational crisis. The company reported negative net sales of ₹0.13 crores, indicating a complete collapse in revenue generation, with a staggering year-on-year decline of 100.33% from ₹39.14 crores in March 2025. This unprecedented situation suggests that the company may have faced substantial sales reversals or accounting adjustments that overwhelmed any minimal revenue generated during the quarter. The net loss for the same period widened to ₹4.16 crores, reflecting a sequential deterioration of 63.14% from the previous quarter's loss of ₹2.55 crores. The operating profit (PBDIT) also deteriorated to a loss of ₹2.11 crores, yielding an operating margin that is rendered meaningless due to the negative revenue base. The company's return on equity (ROE) stands at a low 0.32%, indicating severely weak capi...
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-08-06 10:10:42Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 August 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news articleWhen is the next results date for Lasa Supergenerics Ltd?
2026-08-05 23:20:09Lasa Supergenerics Ltd is scheduled to declare its results on 14 August 2026....
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-07-23 10:10:26Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 February 2025. However, the analysis below reflects the stock’s current position as of 23 July 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.
Read full news article
Lasa Supergenerics Ltd is Rated Strong Sell
2026-07-02 10:10:53Lasa Supergenerics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 11 Feb 2025. However, the analysis and financial metrics discussed here reflect the company’s current position as of 02 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleLasa Supergenerics Limited - Updates
05-Dec-2019 | Source : NSELasa Supergenerics Limited has informed the Exchange regarding 'we have been granted patents for our key products the period of 20 years from the date of Filing'.
Lasa Supergenerics Limited - Corrigendum
27-Nov-2019 | Source : NSELasa Supergenerics Limited has informed the Exchange regarding Corrigendum to detailed public statement published on September 06, 2019 for the attention of equity shareholders of company.
Lasa Supergenerics Limited - Updates
26-Nov-2019 | Source : NSELasa Supergenerics Limited has informed the Exchange regarding 'Letter of Offer'.
Corporate Actions
No Upcoming Board Meetings
Lasa Supergenerics Ltd has declared 2% dividend, ex-date: 16 Sep 22
No Splits history available
No Bonus history available
No Rights history available






